<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82387">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02024048</url>
  </required_header>
  <id_info>
    <org_study_id>ECTP-EDI</org_study_id>
    <nct_id>NCT02024048</nct_id>
  </id_info>
  <brief_title>Evaluation of Choroidal Thickness During Pregnancy Using Enhanced Depth Imaging Optical Coherence Tomography</brief_title>
  <official_title>Evaluation of Choroidal Thickness During Pregnancy Using Enhanced Depth Imaging Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaia Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gaia Hospital</source>
  <oversight_info>
    <authority>Portugal: Health Ethic Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate choroidal thickness and volume during the third
      trimester of pregnancy by comparison with a group of age-matched non-pregnant healthy group
      of women
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pregnant women in the last trimester and age-matched healthy controls have an Optical
      Coherence Tomography (OCT) image taken on the OCT Spectralis® device.

      A map of the choroid in the macular area is constructed automatically. Choroidal thickness
      and volume are calculated for the 9 subfields defined by the Early Treatment Diabetic
      Retinopathy Study (ETDRS).

      A comparative analysis between the two groups will be performed. As a secondary outcome
      measure, the change in choroidal thickness of the pregnant group of women will be assessed
      at 6 months postpartum by comparison to the 3rd trimester of pregnancy.

      The OCT is a non-invasive examination that poses no risk to the mother or the fetus.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Choroidal thickness</measure>
    <time_frame>3rd trimester of pregnancy (from 28 weeks gestation to delivery)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of choroidal thickness between the pregnant group of women and the age-matched group of control subjects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in choroidal thickness</measure>
    <time_frame>During the 3rd trimester (from 28 weeks gestation to delivery) and at 6 months post partum</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in choroidal thickness in the third trimester of pregnancy and at 6 months post partum</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Pregnant</arm_group_label>
    <description>OCT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>OCT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OCT</intervention_name>
    <description>Optical coherence tomography in enhanced depth imaging mode</description>
    <arm_group_label>Pregnant</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy pregnant women in the third trimester of pregnancy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Pregnant women:

          -  uncomplicated pregnancy in the third trimester (from 28 weeks of gestation)

        For both groups:

          -  no systemic or ocular disease

          -  absence of systemic medication other than prenatal vitamins

          -  no smoking habits

          -  emmetropia or a small refractive error (spherical equivalent &lt;1.5 diopters)

        Exclusion Criteria:

          -  any of the above
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renata Rothwell, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Opthalmolgy, Centro Hospitalar Vila Nova de Gaia/Espinho</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sofia Fonseca, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marisa Oliveira, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lígia Ribeiro, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dália Meira, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho Vila Nova de Gaia</name>
      <address>
        <city>Vila Nova de Gaia</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 27, 2014</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gaia Hospital</investigator_affiliation>
    <investigator_full_name>Renata Rothwell</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>OCT</keyword>
  <keyword>Enhanced depth imaging</keyword>
  <keyword>Choroid</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
